Institutional investors purchased a net $3.1 million shares of OMER during the quarter ended March 2014, and now own 39.72% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MEDICAL STRATEGY GMBH Bought 46.5 Thousand shares of Omeros Corp
QUANTBOT TECHNOLOGIES LLC Bought 6.6 Thousand shares of Omeros Corp
MASSACHUSETTS MUTUAL LIFE INSURA... Bought 4.3 Thousand shares of Omeros Corp